Results 101 to 110 of about 702,826 (358)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Dual targeting PET tracer [⁶⁸Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study. [PDF]

Theranostics, 2023
Wang R, Jakobsson V, Wang J, Zhao T, Peng X, Li B, Xue J, Liang N, Zhu Z, Chen X, Zhang J.   +10 more
europepmc   +1 more source

Insulinoma‐associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens [PDF]

, 2018
Erika Doxtader, Sanjay Mukhopadhyay
openalex   +1 more source

Identification of Targets and Active Components of Yiqi SanJie Formula Against Lung Neoplasms Based on Network Pharmacology Analysis and Molecular Docking [PDF]

, 2021
Tian-jiao Zhou, Junfeng Liu, Ping Wang, Anna Hu, Linlin Chen, Jun-Feng Zan   +5 more
openalex   +1 more source

Possible role of GADD45γ methylation in diffuse large B-cell Lymphoma: Does it affect the progression and tissue involvement? [PDF]

, 2015
Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma among adults and is characterized by heterogeneous clinical, immunophenotypic, and genetic features.
Barış, İkbal Cansu, Bağcı, Gülseren, Can, Özge, Caner, Vildan, Doğu, Mehmet Hilmi, Hacıoğlu, Sibel, Keskin, Ali, Sarı, İsmail, Tepeli, Emre, Türk, Nilay Şen, Çetin, Ozan   +10 more
core   +2 more sources

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Breast metastasis from lung adenocarcinoma: a case report and review of the literature

Frontiers in Oncology
Lung cancer (LC) is one of the most lethal and most prevalent malignant tumors, and lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer.
Jialing Ding, Huayan Gu, Zhi Yang, Yiqiao Lu, Guilong Guo   +4 more
doaj   +1 more source

Pulmonary artery resection with autologous pericardial conduit to avoid pneumonectomy in lung neoplasms surgery: How to do it. [PDF]

JTCVS Tech, 2023
Madelaine L, Bernard A, Hanna HA, Moret A, Pagès PB.   +4 more
europepmc   +1 more source

Hong H‐HL, Dunnick J, Herbert R, Devereux TR, Kim Y, Sills RC (2007): Genetic alterations in K‐ras and p53 cancer genes in lung neoplasms from Swiss (CD‐1) male mice exposed transplacentally to AZT. Environ Mol Mutagen 48:299–306. [PDF]

, 2007

openalex   +1 more source

Adjuvant therapy for lung neuroendocrine neoplasms

, 2021
Robert A. Ramirez, Katharine Thomas, Aasems Jacob, Karen Lin, Yvette Bren‐Mattison, Aman Chauhan   +5 more
openalex   +1 more source